Table 2.
All | |
---|---|
Age, years | |
Median | 53 |
Range | 25–84 |
Tumour size, cm | |
Median | 8.5 |
Range | 1.0–22.3 |
Tumour number | |
Median | 2 |
Range | 1–11 |
Gender | |
Male | 13 (33%) |
Female | 26 (67%) |
Margin | |
R0 | 11 (28%) |
R1 | 11 (28%) |
R2 | 15 (39%) |
Grade | |
Low | 19 (49%) |
Intermediate | 13 (33%) |
High | 7 (18%) |
Primary site | |
Pancreas | 11 (28%) |
Small bowel | 8 (21%) |
Unknown | 14 (36%) |
Other | 6 (15%) |
Symptoms | |
Present | 28 (72%) |
Octreotide therapy | |
Yes | 11 (28%) |
Chemotherapy | |
Yes | 10 (26%) |
Embolization | |
Yes | 15 (39%) |
CD3 | |
High (2–3) | 23 (59%) |
Low (0–1) | 16 (41%) |
CD4 | |
High (3) | 21 (54%) |
Low (0–2) | 18 (46%) |
CD8 | |
High (2–3) | 22 (56%) |
Low (0–1) | 17 (44%) |
FoxP3 | |
High (1–3) | 13 (33%) |
Low (0) | 26 (67%) |